INTRODUCTION
Nephrotoxic serum nephritis (NSN),' produced by the administration of heterologous antibody to glomerular basement membrane (GBM) is a well-established experimental model of glomerular immune injury re-sulting in glomerulonephritis and the nephrotic syndrome (1) . This model of glomerular injury is characterized by a reproducible sequence of morphologic and pathophysiologic events that render it suitable for biochemical studies.
The involvement of a variety of cellular (2, 3) and humoral (4) mediators has been demonstrated in experimental anti-GBM nephritis, with potential roles attributed to changes in glomerular permeability to macromolecules (5) , effects on glomerular vasculature (6) , and chemotaxis of leukocytes into the glomerulus (7) . The renal glomerulus has recently been shown to oxygenate arachidonic acid enzymatically through the cyclooxygenase (8) and the lipoxygenase (9) pathways to prostaglandins (PG), thromboxane, and hydroxylated fatty acids. These compounds have potent vasoactive (10) and chemotactic (11) properties and therefore could mediate, at least partially, pathophysiologic changes occurring in the course of experimental anti-GBM disease (12) .
Our study evaluates the arachidonate cyclooxygenation and PG synthetic patterns in glomeruli isolated from rats with NSN. Furthermore, we assessed the pathophysiologic role of glomerular prostanoids, and in particular thromboxane A2 (TxA2), as mediators of the renal hemodynamic changes after administration of anti-GBM serum.
METHODS
Preparation and testing of anti-rat GBM serum. Anti-GBM serum was produced by immunization of three male albino rabbits with rat particulate GBM prepared from frozen rat kidneys (Pel-Freeze Biologicals, Inc., Rogers, AR) by a modification of the method of Krakower and Greenspon (13) . The rabbits received six bimonthly injections (intradermally) of 5 mg rat GBM in complete Freund's adjuvant. Nephrotoxicity of rabbit sera was assessed at various time intervals: during the period of immunization, by the development of acute proteinuria after injection of 1 ml serum i.v. in male Sprague Dawley rats, and by morphologic evaluation of glomeruli under light, immunofluorescence, and electron microscopy.
When rabbit anti-rat GBM sera attained a sufficient titer to produce nephrotoxic lesions, the sera were pooled, complement inactivated at 56°C for 30 min, and absorbed with rat peripheral blood cells. The immune gamma globulin fraction, corresponding to 1 ml of pooled rabbit serum, was then estimated after gamma globulin isolation from an aliquot of the pool by the DEAE-cellulose method of Stanworth (14) . In all subsequent experiments, 1 ml of rabbit anti-rat GBM serum (nephrotoxic serum, NTS) was employed. Induction of anti-GBM disease. Male Sprague-Dawley rats, 250-300 g, were kept in metabolic cages with free access to standard diet and water. On day 0, anti-GBM disease was induced by the intravenous administration of 1 ml of rabbit anti-rat GBM serum, corresponding to a gamma globulin dose of [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] Ag/I00 g body wt. Control rats received 1 ml of serum obtained from rabbits immunized solely with complete Freund's adjuvant. The course of the NSN was evaluated over a 14-d period by daily determinations of 24-h urine protein excretion (15) and glomerular morphology according to standard methods for light, immunofluorescence, and electron microscopy.
Glomerular biochemical studies. On days 2, 8, 11 , and 14 after administration of the NTS, rats were nephrectomized and the kidneys were placed in phosphate-buffered saline containing 150 mM NaCl, 10.5 mM Na2HPO4, and 3.8 mM NaH2PO4 (pH 7.4) at 4°C. Cortices from right and left kidneys were dissected from the medullae and processed separately for glomerular isolation; thus, two observations were obtained in each animal. After mincing of the cortices to a pastelike consistency, glomeruli were isolated by a technique previously used in this laboratory for glomerular biochemical studies (8) . The minced cortical tissue was initially passed through a 106-,um metal sieve to remove large tubular fragments and the glomeruli were subsequently trapped on a 75-Am sieve. The purity of glomerular yields was determined microscopically, by counting the number of glomerular and nonglomerular particles suspended in a small volume of phosphate-buffered saline, and was found to vary between 88 and 95%. Glomeruli were generally devoid of Bowman's capsule and arterioles.
Isolated glomeruli were then suspended in preweighed, siliconized glass culture tubes in modified Earle's balanced salt solution, pH 7.4, containing gelatin 0.01 mg/ml, 25 mM n-2-hydroxyethylpiperazine-n'-2-ethanesulfonic acid (Hepes), and 5,8,11,14-eicosatetraenoic acid (arachidonic acid (C20:4), Sigma Chemical Co., St. Louis, MO) at a concentration of 5 gg/ml. Stock solutions of C20:4 dissolved in hexane at a concentration of 5 mg/ml, were kept at -35°C and were generally used within less than 1 mo of storage. Before each use, a 50-,gl aliquot of stock C20:4 solution was dried under N2 and 50 Ml absolute ethyl alcohol was added. 5 gA of this solution were added in 5 ml modified Earle's solution, thus yielding a concentration of 5 ug/ml C20:4 and 0.1% ethanol. Glomeruli were then incubated in a volume of 1.5 ml media at 370C for 45 min, without agitation. At the end of incubation, the glomeruli were centrifuged at 3,000 rpm for 10 min, the supernates were removed and frozen, and the wet weight of glomerular pellets was determined. Glomerular cyclooxygenation of C20:4 was assessed by determination of the major immunoreactive products of the cyclooxygenase pathway in.the glomerular incubates, namely prostaglandin E2 (PGE2), prostaglandin F2a (PGF2ia), thromboxane B2 (TxB2) (the stable degradation product of TxA2) and 6-ketoprostaglandin Fl,. ( histamine-6-keto-PGFI,, and '"I-histamine-TxB2 were used as ligands for the radioimmunoassays (RIA) of 6-keto-PGFIa and TxB2. These were made in our laboratory by the method of Maclouf et al. (17) . The sensitivities and cross-reactivities of these four RIA have been previously described (18 70-Al blood samples were obtained from the tail vein at the midpoint of each clearance period. Urine was collected in preweighed vessels via a large-bore polyethylene tube inserted in the bladder via a small incision at the fundus. Plasma and urine inulin and PAH were determined by methods previously described (19, 20) , modified for microliter samples.
In experiments involving infusions of NTS and/or inhibitors, arterial blood pressure was monitored constantly via a polyethylene tubing inserted in the femoral artery and connected to a Gould brush 220 recorder (Gould Instruments Div., Gould, Inc., Cleveland, OH) via a carrier amplifier. Each experiment involved four clearance periods. The first 40-min clearance preceded administration of NTS. The second 40-min clearance period was initiated 20 min after the intravenous infusion (>4-5 min) of 1 ml NTS and was followed by a third and fourth clearance, each of 60 min duration. At the end of the fourth clearance period, rats were nephrectomized and glomeruli were isolated and processed for biochemical studies as described above. In a group of rats, clearances were terminated and glomerular studies were performed at 1 (n = 6), 2 (n = 4), and 3 h (n = 4) after administration of NTS. Control rats received 1 ml of nonnephrotoxic serum from rabbits injected only with Freund's adjuvant. Thus, the time sequence of glomerular arachidonate cyclooxygenation and PG synthetic profiles was assessed in parallel with pathophysiologic changes.
In 13 thromboxane synthetase inhibition experiments, the inhibitor sodium (E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl acrylate, also known as OKY-1581, (Ono Pharmaceutical Co., Osaka, Japan) was infused along with the inulin-PAH solutions for 100 min before and during the administration of NTS and throughout all three clearance periods after NTS infusion. A loading dose of OKY-1581, 150 jtg, dissolved in the priming inulin-PAH solution, was followed by varying amounts of the inhibitor infused constantly with the sustaining inulin-PAH solution. In all inhibition experiments, the loading dose was kept constant, while three different sustaining infusion rates of the inhibitor were used: 150 (n = 3), 450 (n = 4), and 1,500 (n = 6) Ag/h. Clearance and postsacrifice glomerular prostaglandin values were compared with parallel experiments (n = 8) using NTS infusions alone.
In four additional thromboxane synthetase inhibition experiments, the effect of the inhibitor 3-(1H-imidazol-1-ylmethyl)-2-methyl-lH-indole-1-propanoic acid, also known as UK-38485, (Pfizer Chemicals Div., Pfizer Inc., Groton, CT) on renal hemodynamic changes induced by NTS Fig. 2 . On day 2 after induction of NSN, there was a 10-fold increment of glomerular TxA2 release, with smaller increases in the synthesis of PGE2 and PGF2a (4-and 2.3-fold respectively). On days 8, 11, and 14, only glomerular TxA2 synthesis remained enhanced.
To assess the contribution of circulating cells, especially platelets and leukocytes on glomerular arachidonate cyclooxygenation, kidneys were perfused free of blood on day 2 in four control and four nephritic rats. Renal perfusion had no effect on glomerular PG and TxA2 synthesis in glomeruli from control or NSN rats, suggesting no significant contribution of bloodborne cells entrapped in glomerular capillaries.
To assess the possible association of glomerular TxA2 synthesis with glomerular injury, TxB2 synthetic rates were correlated with the urinary protein excretion. A significant correlation (r = 0.66, P < 0.05, n = 13) was found between glomerular TxB2 synthesis and urinary protein excretion determined in the 24-h collections just before the animal was killed (Fig. 3) . Glomerular PGF2a and PGE2 synthesis did not correlate with protein excretion.
Acute effects of NTS on renal hemodynamics and glomerular PG synthesis. Fig. 4 depicts the sequence of acute changes in GFR and RPF, after NTS, in parallel with changes in glomerular PG synthesis, determined in vitro, and expressed as fold-increments compared with simultaneous controls (NTN/control). At 1 h, there was a significant decrement in the inulin clearance rate (CIN) (0.66±0.04 to 0.44±0.03 ml/min per 100 g, P < 0.05), accompanied by an insignificant change in the PAH clearance rate (CPAti) (1.97±0.23 to 1.80±0.23 ml/min per 100 g). Glomerular PG synthesis was unaltered compared with simultaneous controls. At 2 h, CIN further decreased to 0.25±0.04 ml/ min per 100 g, P < 0.01 compared with the preceding hour and CPAH fell to 1.30±0.1 ml/min per 100 g, P < 0.05. The synthesis of TxB2 and PGF2a were enhanced by 4.6±0.1-(P < 0.0001) and 1.7±0.5-fold (P < 0.05), respectively. At 3 h, there was a significant recovery of CIN to 0.43±0.07 ml/min per 100 g, (P < 0.05) and CPAH to 1.77±0.20 ml/min per 100 g (P experiments using NTS alone. When OKY-1581 was infused at rates of 1,500 ag/h (n = 6), FIGURE 1 (a) Glomerulus at 3 h after injection of anti-GBM serum. The capillary lumen is obliterated by a PMN. The endothelium of the capillary (arrow) is missing. X 4,000. (b) Glomerulus at day 2 after injection of anti-GBM serum. The lumen of the capillary is obliterated by two mononuclear cells. The cell on the right has abundant endoplasmic reticulum and might be endothelial or blood-borne. The cell on the left is a monocyte (MNC) that has penetrated between the lifted endothelium (arrow) and the naked basement membrane X 8,000. UPROTXV: mg/24h FIGURE 3 Correlation between the presacrifice 24-h urinary protein excretion (UPROTXv) and the postsacrifice glomerular TxB2 synthetic rates in animals studied between 2 and 14 d after a single administration of NTS. n = 13; r = 0.66, and P < 0.05. glomerular TxB2 synthesis was uniformly inhibited (TxB2 synthetic rates: 14-33 pg/mg glomerular wt per 45 min). The changes of CIN at 1, 2, and 3 h after NTS infusion (n = 8) and their modification by OKY-1581 infused at a loading dose of 150 ,ug, followed by 1,500 ug/h (n = 6), are shown in Fig. 5 were not altered (Fig. 6 ). Effects of ibuprofen (Fig. 7) . Ibuprofen, a cyclooxygenase inhibitor, administered i.v., 13 mg/kg, and i.p., 13 mg/kg, did not prevent the decrements of GFR and RPF at 1 and 2 h after NTS infusion. In the rats receiving ibuprofen, the partial recovery in GFR at 3 h was attenuated compared with NTS control animals (0.62±0.03 compared with 0.88±0.12 ml/min per 100 g body wt, P < 0.05) (Fig. 7) . Ibuprofen also blocked the partial recovery in CPAH (1.96±0.37 compared with 2.77±0.18 ml/min per 100 g body wt, P < 0.05, not shown). Despite adequate serum thromboxane inhibition, ibuprofen did not inhibit glomerular TxA2 synthesis compared with NTS control animals. In fact, glomerular TxB2 values were significantly higher in the ibuprofen-treated group (985±120 compared with 840±101 pg/mg glomerular wt, P < 0.005) and glomerular PGE2 and 6-kto-PGF1a were significantly lower than in NTS controls (PGE2: 484±59 compared with 1,044±116 pg/mg glomerular wt, P pg/mg glomerular wt).
In Fig. 8 , CIN in the hour before the animal was killed is correlated with in vitro glomerular TxA2 synthetic rates in all clearance experiments (n = 22) involving administration of NTS alone and NTS with OKY-1581 at three different infusion rates (150, 450, and 1,500 pg/h). A significant inverse correlation was found (r = 0.67, P < 0.01). An inverse correlation was also found between glomerular TxB2 synthesis and filtration fraction (r = 0.57, P < 0.05, data not shown). Synthesis of PGE2 and 6-keto-PGF,. were unaltered. NSN, induced by administration of anti-GBM antibody, is associated with a spectrum of pathophysiologic changes and involves a variety of cellular and humoral mediators in the host. Systems that are thought to mediate or induce glomerular structural and functional damage include polymorphonuclear leukocytes (PMN) and monocytes (3, 23) , platelets (24) , the complement system (25), the Hageman factor system (26) , and vasoactive amines (6) .
A potential role of C20:4 metabolites in glomerular immune injury can be reasoned on the basis of several lines of evidence: (a) Cyclooxygenase inhibition has been shown to decrease urinary protein excretion, particularly when combined with volume depletion, in patients with various forms of immunologically mediated glomerulopathies (27) . (b) Isolated glomeruli (8) , glomerular epithelial cells (28) , and glomerular mesangial cells (29) are capable of cyclooxygenating C20:4 to PGF2a and PGE2 and to a lesser extent TxA2 and 6-keto-PGFIa. (c) Cells (leukocytes, monocytes, platelets) invariably present in the course of anti-GBM disease and thought to be involved in mediating glomerular injury synthesize PG and TxA2 (30) (31) (32) .
The results of our study indicate that enhanced arachidonate cyclooxygenation by isolated glomeruli commences as early as 2 h after administration of NTS (Fig. 4) . The synthesis of TxB2 and PGF2a were increased within 2 h, whereas PGE2 and 6-keto-PGFIa were enhanced after 3 h. On day 2, TxB2, PGF2a, and PGE2 continued to be produced at increased rates, with TxB2 showing the greatest increment. Throughout the rest of the 2-wk course, namely on days 8, 11, and 14, only TxB2 synthesis remained enhanced (Fig. 2) .
Several sources of PG and TxA2 synthesis can be implicated in this model of glomerular immune injury. Blood-borne cells (leukocytes, monocytes, platelets) recruited to sites of antigen-antibody interaction and complement activation along the GBM, could account for the enhanced PG and TxA2 synthetic rates. In experimental anti-GBM disease, when complement-fixing anti-GBM antibodies are used, there is an influx of PMN, eventually replaced by mononuclear cells (33) . Light and electron microscopic evaluation of glomerular cellularity (Fig. 1 a) demonstrated the presence of PMNs within 3 h after NTS infusion. An endogenous glomerular source of prostanoids is also possible, since both epithelial and mesangial cells are capable of synthesizing PG and thromboxanes (28, 29, 34) . Mesangial cell proliferation is a common feature of nephrotoxic glomerulonephritis and was seen during the heterologous phase in all animals studied. Furthermore, mesangial cells have been reported to be involved in glomerular morphologic changes as early as 20 min after injection of NTS, with mesangial cell interposition between endothelial cells and GBM occurring before the PMN influx (35) .
Evidence that the enhanced glomerular PG and TxA2 synthesis may not be entirely from blood-borne cellular sources includes the following observations: (a) Renal perfusion to remove nonadherent cells decreased glomerular cellularity, assessed histologically, and did not significantly reduce PG and TxA2 synthesis in NSN glomeruli compared with contralateral nonperfused NSN controls. (b) OKY-1581 at 150 and at 450 ag/h induced a 97% inhibition of serum (primarily platelet) TxA2, but did not uniformly inhibit glomerular TxA2 synthesis. (c) Ibuprofen had no effect on glomerular TxA2 synthesis despite a 95-97% inhibition of serum TxA2. It should be pointed out, however, that both perfusion techniques and pharmacologic maneuvers might be ineffective in removing or inhibiting blood-borne cells that have migrated into the mesangium.
The anti-GBM antibody induced changes in renal and glomerular hemodynamics have been studied by several groups. These investigators have assessed both the immediate (45-60 min) and the late (5-20 mo) effects of anti-GBM sera (12, 36, 37) . A key feature of NTS-induced hemodynamic changes is reduction in whole kidney and single nephron GFR, attributable primarily to decrements in ultrafiltration coefficient and in single nephron RPF, the latter being dependent on the amount of immune globulin infused (38) .
In our studies, NTS reduced the GFR as early as 1 h with a nadir at 2 h and partial recovery by 3 h. Glomerular TxA2 was normal at 1 h and was increased 4.6-and 1 1-fold at 2 and 3 h, respectively. To evaluate the pathophysiologic importance of TxA2 in this NSN model, we used two different inhibitors of TxA2 synthetase. OKY-1581 is a pyridine derivative which inhibits TxA2 production in vitro (39) and in vivo (40) . UK-38485, an imidazole compound, is also a potent TxA2 inhibitor (41) . Neither drug inhibits cyclooxygenase at doses necessary to decrease TxA2 (39-41). In our experiments both OKY-1581 (1,500 Ag/h) and UK-38485 (400 ,g/h) completely blocked the increment of glomerular TxA2 after induction of NSN. Biochemical inhibition of TxA2 synthesis, in glomeruli, prevented the expected decrements of GFR, RPF and filtration fraction at 2 and 3 h after NTS. OKY-1581, but not UK-38485, also improved the GFR at 1 h, perhaps through pharmacologic actions apart from TxA2 inhibition, since glomerular TxA2 was normal at 1 h. Blantz et al. (42) have postulated that alpha adrenergic stimulation accounts for the decrements of GFR 45-60 min after administration of NTS. The partial recovery of GFR at 3 h occurred despite further increments in glomerular TxA2 synthesis. This recov-ery coincided with significant increments in the synthesis of glomerular PGE2, PGF2a, and 6-keto-PGFia.
Ibuprofen attenuated the partial recovery in GFR and effective RPF (Fig. 7) . Although used in large doses, ibuprofen failed to decrease glomerular TxA2 synthesis, whereas it did reduce the synthetic rates of PGE2 and 6-keto-PGFia. These observations support a role for these vasodilatory PG in mediating the partial recovery in GFR and RPF at 3 h after NTS infusion.
Potential sites of action of TxA2 on glomerular vasculature are the afferent and efferent arterioles, which have increased resistance after administration of anti-GBM serum (38) . Since in our studies GFR decreased more than RPF, an effect of thromboxane on the factors regulating glomerular filtration could be postulated. Of these factors, the ultrafiltration coefficient, which is the product of filtration surface area and hydraulic conductivity, appears to be particularly sensitive to the effects of anti-GBM serum (36, 38) . A decrement in hydraulic conductivity after NTS infusion has been postulated (36) on the basis of detachment of the endothelial lining commonly observed, thereby creating an unstirred layer. On the other hand, changes in filtration surface area could result from changes in contractility of the glomerular mesangial cells (43, 44 
